Patent | Date |
---|
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases App 20220233505 - Dibas; Mohammed I. ;   et al. | 2022-07-28 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20220202777 - Beard; Richard L. ;   et al. | 2022-06-30 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Grant 11,331,306 - Dibas , et al. May 17, 2 | 2022-05-17 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol App 20220008393 - Dibas; Mohammed I. ;   et al. | 2022-01-13 |
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof Grant 11,208,377 - Hein , et al. December 28, 2 | 2021-12-28 |
Sulfur derivatives as chemokine receptor modulators Grant 11,046,644 - Yuan , et al. June 29, 2 | 2021-06-29 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 10,993,931 - Beard , et al. May 4, 2 | 2021-05-04 |
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Grant 10,899,780 - Beard , et al. January 26, 2 | 2021-01-26 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases App 20210008085 - Viswanath; Veena ;   et al. | 2021-01-14 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases App 20210000846 - Viswanath; Veena ;   et al. | 2021-01-07 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases App 20200390747 - Dibas; Mohammed I. ;   et al. | 2020-12-17 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20200330428 - Gil; Daniel W. ;   et al. | 2020-10-22 |
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases Grant 10,799,518 - Viswanath , et al. October 13, 2 | 2020-10-13 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases App 20200246360 - Kind Code | 2020-08-06 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol App 20200206193 - Dibas; Mohammed I. ;   et al. | 2020-07-02 |
Prostacyclin Receptor Agonists For Reduction Of Body Fat App 20200171026 - Li; Yong-Xin ;   et al. | 2020-06-04 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20200109110 - YUAN; HAIQING ;   et al. | 2020-04-09 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Grant 10,555,933 - Dibas , et al. Feb | 2020-02-11 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20190343804 - Beard; Richard L. ;   et al. | 2019-11-14 |
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases Grant 10,434,112 - Viswanath , et al. O | 2019-10-08 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases App 20190240200 - Dibas; Mohammed I. ;   et al. | 2019-08-08 |
Compositions Including Encapsulated Isotretinoin And Methods For Use Thereof App 20190192467 - Donello; John E. ;   et al. | 2019-06-27 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases App 20190153004 - Beard; Richard L. ;   et al. | 2019-05-23 |
Sulfur derivatives as chemokine receptor modulators Grant 10,287,243 - Yuan , et al. | 2019-05-14 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Grant 10,251,865 - Gil , et al. | 2019-04-09 |
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Grant 10,208,071 - Beard , et al. Feb | 2019-02-19 |
3,4-disubstituted 3-cyclobutene-1,2-diones And Use Thereof App 20190047947 - Hein; Christopher D. ;   et al. | 2019-02-14 |
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Grant 10,201,535 - Dibas , et al. Feb | 2019-02-12 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 10,172,832 - Beard , et al. J | 2019-01-08 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20180344692 - Gil; Daniel W. ;   et al. | 2018-12-06 |
Compositions including encapsulated isotretinoin and methods for use thereof Grant 10,123,988 - Donello , et al. November 13, 2 | 2018-11-13 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20180228772 - Beard; Richard L. ;   et al. | 2018-08-16 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 9,974,772 - Beard , et al. May 22, 2 | 2018-05-22 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists App 20180071259 - Gil; Daniel W. ;   et al. | 2018-03-15 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20180071260 - Gil; Daniel W. ;   et al. | 2018-03-15 |
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,902,710 - Leblond , et al. February 27, 2 | 2018-02-27 |
Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect Grant 9,889,088 - Dibas , et al. February 13, 2 | 2018-02-13 |
Carbamoyl hydrazine derivatives as formyl peptide modulators Grant 9,868,700 - Vuligonda , et al. January 16, 2 | 2018-01-16 |
Methods of treating .alpha. adrenergic mediated conditions Grant 9,849,113 - Gil , et al. December 26, 2 | 2017-12-26 |
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases Grant 9,850,264 - Beard , et al. December 26, 2 | 2017-12-26 |
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Grant 9,828,349 - Leblond , et al. November 28, 2 | 2017-11-28 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases App 20170320897 - Beard; Richard L. ;   et al. | 2017-11-09 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases App 20170216326 - Viswanath; Veena ;   et al. | 2017-08-03 |
Carbamoyl Hydrazine Derivatives As Formyl Peptide Modulators App 20170183298 - Vuligonda; Vidyasagar ;   et al. | 2017-06-29 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20170182028 - Dibas; Mohammed I. ;   et al. | 2017-06-29 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20170172982 - Gil; Daniel W. ;   et al. | 2017-06-22 |
D-serine For The Treatment Of Visual System Disorders App 20170172959 - Li; Yong-Xin ;   et al. | 2017-06-22 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol App 20170172983 - Dibas; Mohammed I. ;   et al. | 2017-06-22 |
(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators Grant 9,670,150 - Beard , et al. June 6, 2 | 2017-06-06 |
Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators Grant 9,670,190 - Beard , et al. June 6, 2 | 2017-06-06 |
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,670,181 - Leblond , et al. June 6, 2 | 2017-06-06 |
Carbamoyl hydrazine derivatives as formyl peptide modulators Grant 9,663,457 - Beard , et al. May 30, 2 | 2017-05-30 |
Sulfur derivatives as chemokine receptor modulators Grant 9,663,460 - Yuan , et al. May 30, 2 | 2017-05-30 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20170119737 - Beard; Richard L. ;   et al. | 2017-05-04 |
Treatment of inflammatory bowel disease Grant 9,637,467 - Donde , et al. May 2, 2 | 2017-05-02 |
Methods of treating .alpha. adrenergic mediated conditions Grant 9,623,006 - Gil , et al. April 18, 2 | 2017-04-18 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20170095466 - Dibas; Mohammed I. ;   et al. | 2017-04-06 |
1,2- bis-sulfonamide derivatives as chemokine receptor modulators Grant 9,603,834 - Yuan , et al. March 28, 2 | 2017-03-28 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists App 20170079956 - Gil; Daniel W. ;   et al. | 2017-03-23 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 9,579,307 - Beard , et al. February 28, 2 | 2017-02-28 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20170050925 - YUAN; HAIQING ;   et al. | 2017-02-23 |
Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators Grant 9,550,746 - Yuan , et al. January 24, 2 | 2017-01-24 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Grant 9,545,394 - Gil , et al. January 17, 2 | 2017-01-17 |
Alpha adrenergic receptor modulators Grant 9,522,150 - Chow , et al. December 20, 2 | 2016-12-20 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions App 20160354346 - Dibas; Mohammed I. ;   et al. | 2016-12-08 |
Compositions for treating cognitive disorders Grant 9,492,543 - Staubli , et al. November 15, 2 | 2016-11-15 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases App 20160303083 - Dibas; Mohammed I. ;   et al. | 2016-10-20 |
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20160264549 - Leblond; Bertrand ;   et al. | 2016-09-15 |
Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators Grant 9,428,549 - Beard , et al. August 30, 2 | 2016-08-30 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20160235711 - Beard; Richard L. ;   et al. | 2016-08-18 |
Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators Grant 9,416,120 - Yuan , et al. August 16, 2 | 2016-08-16 |
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators App 20160228407 - Yuan; Haiqing ;   et al. | 2016-08-11 |
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Grant 9,399,628 - Leblond , et al. July 26, 2 | 2016-07-26 |
Sulfur derivatives as chemokine receptor modulators Grant 9,371,278 - Yuan , et al. June 21, 2 | 2016-06-21 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists App 20160158199 - Gil; Daniel W. ;   et al. | 2016-06-09 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20160151349 - Dibas; Mohammed I. ;   et al. | 2016-06-02 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 9,351,948 - Beard , et al. May 31, 2 | 2016-05-31 |
Sulfur derivatives as chemokine receptor modulators Grant 9,328,067 - Yuan , et al. May 3, 2 | 2016-05-03 |
Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds Grant 9,314,466 - Donello , et al. April 19, 2 | 2016-04-19 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Grant 9,308,201 - Dibas , et al. April 12, 2 | 2016-04-12 |
Treatment Of Inflammatory Bowel Disease App 20160096817 - Donde; Yariv ;   et al. | 2016-04-07 |
Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds Grant 9,303,021 - Donello , et al. April 5, 2 | 2016-04-05 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20160083342 - YUAN; HAIQING ;   et al. | 2016-03-24 |
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20160083371 - Leblond; Bertrand ;   et al. | 2016-03-24 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Grant 9,289,420 - Gil , et al. March 22, 2 | 2016-03-22 |
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions Grant 9,283,217 - Dibas , et al. March 15, 2 | 2016-03-15 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol App 20160067222 - Dibas; Mohammed I. ;   et al. | 2016-03-10 |
Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds Grant 9,278,943 - Leblond , et al. March 8, 2 | 2016-03-08 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8- Tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20160051534 - Dibas; Mohammed I. ;   et al. | 2016-02-25 |
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20160051555 - Donello; John E. ;   et al. | 2016-02-25 |
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A) Grant 9,200,016 - Leblond , et al. December 1, 2 | 2015-12-01 |
Carbamoyl Hydrazine Derivatives As Formyl Peptide Modulators App 20150291511 - Beard; Richard L. ;   et al. | 2015-10-15 |
Treatment of inflammatory bowel disease Grant 9,156,810 - Donde , et al. October 13, 2 | 2015-10-13 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases App 20150250764 - Dibas; Mohammed I. ;   et al. | 2015-09-10 |
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20150231140 - Donello; John E. ;   et al. | 2015-08-20 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20150231128 - Dibas; Mohammed I. ;   et al. | 2015-08-20 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20150224080 - Gil; Daniel W. ;   et al. | 2015-08-13 |
Benzofuran-2-sulfonamides Derivatives As Chemokine Receptor Modulators App 20150218119 - YUAN; HAIQING ;   et al. | 2015-08-06 |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases Grant 9,095,576 - Dibas , et al. August 4, 2 | 2015-08-04 |
Alpha Adrenergic Receptor Modulators App 20150209351 - Chow; Ken ;   et al. | 2015-07-30 |
Aromatic bycyclic derivatives as CXCR4 receptor modulators Grant 9,090,624 - Vuligonda , et al. July 28, 2 | 2015-07-28 |
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20150158895 - Leblond; Bertrand ;   et al. | 2015-06-11 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20150148395 - Beard; Richard L. ;   et al. | 2015-05-28 |
Alpha adrenergic receptor modulators Grant 9,040,532 - Chow , et al. May 26, 2 | 2015-05-26 |
Methods of treating alpha adrenergic mediated conditions Grant 9,034,910 - Gil , et al. May 19, 2 | 2015-05-19 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,993,780 - Beard , et al. March 31, 2 | 2015-03-31 |
Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Modulators App 20150025021 - Beard; Richard L. ;   et al. | 2015-01-22 |
Treatment Of Inflammatory Bowel Disease App 20150018400 - DONDE; YARIV ;   et al. | 2015-01-15 |
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity Grant 8,927,589 - Leblond , et al. January 6, 2 | 2015-01-06 |
Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators Grant 8,927,544 - Yuan , et al. January 6, 2 | 2015-01-06 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20140378492 - YUAN; HAIQING ;   et al. | 2014-12-25 |
Benzofuran-2-sulfonamides Pyridine Derivatives As Chemokine Receptor Modulators App 20140329813 - Yuan; Haiqing ;   et al. | 2014-11-06 |
Sulfur derivatives as chemokine receptor modulators Grant 8,877,804 - Yuan , et al. November 4, 2 | 2014-11-04 |
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a) App 20140309253 - Leblond; Bertrand ;   et al. | 2014-10-16 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases Grant 8,853,251 - Dibas , et al. October 7, 2 | 2014-10-07 |
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20140296287 - Donello; John E. ;   et al. | 2014-10-02 |
Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,846,760 - Beard , et al. September 30, 2 | 2014-09-30 |
Compositions Including Encapsulated Isotretinoin And Methods For Use Thereof App 20140271875 - Donello; John E. ;   et al. | 2014-09-18 |
Alpha-2 Adrenergic Agonist For Treating Intraocular Pressure And Ocular Diseases Through Intravitreal And Intracameral Routes App 20140275197 - DIBAS; Mohammed I. ;   et al. | 2014-09-18 |
Pyridinyl And Pyrimidinyl Sulfonamide Derivatives As Chemokine Receptor Modulators App 20140275132 - Beard; Richard L. ;   et al. | 2014-09-18 |
Compounds having analgesic and/or immunostimulant activity Grant 8,835,463 - Leblond , et al. September 16, 2 | 2014-09-16 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases App 20140256684 - Beard; Richard L. ;   et al. | 2014-09-11 |
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases App 20140256685 - Beard; Richard L. ;   et al. | 2014-09-11 |
Sulfur derivatives as chemokine receptor modulators Grant 8,822,530 - Yuan , et al. September 2, 2 | 2014-09-02 |
Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators Grant 8,815,915 - Yuan , et al. August 26, 2 | 2014-08-26 |
Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,816,076 - Beard , et al. August 26, 2 | 2014-08-26 |
1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,809,367 - Beard , et al. August 19, 2 | 2014-08-19 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20140221481 - YUAN; HAIQING ;   et al. | 2014-08-07 |
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators App 20140221351 - YUAN; HAIQING ;   et al. | 2014-08-07 |
Sulfur derivatives as chemokine receptor modulators Grant 8,791,161 - Yuan , et al. July 29, 2 | 2014-07-29 |
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A) Grant 8,772,316 - Leblond , et al. July 8, 2 | 2014-07-08 |
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20140179925 - Donello; John E. ;   et al. | 2014-06-26 |
Geminal dialkyl prostanoids Grant 8,754,122 - Donde , et al. June 17, 2 | 2014-06-17 |
Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators Grant 8,729,096 - Beard , et al. May 20, 2 | 2014-05-20 |
1,2- bis-sulfonamide derivatives as chemokine receptor modulators Grant 8,729,066 - Yuan , et al. May 20, 2 | 2014-05-20 |
Treating ocular diseases using peroxisome proliferator--activated receptor delta antagonists Grant 8,729,042 - Rodrigues , et al. May 20, 2 | 2014-05-20 |
Dihydronaphthalene And Naphthalene Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20140128471 - Beard; Richard L. ;   et al. | 2014-05-08 |
Therapeutic Quinoline And Naphthalene Derivatives App 20140107153 - Beard; Richard L. ;   et al. | 2014-04-17 |
Methods For Treating Cognitive Disorders App 20140107158 - Donello; John E. ;   et al. | 2014-04-17 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20140094614 - Beard; Richard L. ;   et al. | 2014-04-03 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists App 20140066483 - Gil; Daniel W. ;   et al. | 2014-03-06 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases App 20140057958 - DIBAS; Mohammed I. ;   et al. | 2014-02-27 |
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,658,803 - Beard , et al. February 25, 2 | 2014-02-25 |
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators App 20140051682 - Yuan; Haiqing ;   et al. | 2014-02-20 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases Grant 8,653,123 - Dibas , et al. February 18, 2 | 2014-02-18 |
Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,653,299 - Vuligonda , et al. February 18, 2 | 2014-02-18 |
Methods for treating cognitive disorders Grant 8,629,165 - Donello , et al. January 14, 2 | 2014-01-14 |
S1p3 Receptor Inhibitors For Treating Pain App 20140011771 - Donello; John E. ;   et al. | 2014-01-09 |
Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds Grant 8,623,891 - Donello , et al. January 7, 2 | 2014-01-07 |
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity Grant 08618163 - | 2013-12-31 |
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity Grant 8,618,163 - Beard , et al. December 31, 2 | 2013-12-31 |
Therapeutic quinoline and naphthalene derivatives Grant 8,614,326 - Beard , et al. December 24, 2 | 2013-12-24 |
Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators App 20130338187 - Beard; Richard L. ;   et al. | 2013-12-19 |
6-substituted Indole-3-carboxylic Acid Amide Compounds Having Sphingosine-1-phosphate (s1p) Receptor Antagonist Biological Activity App 20130338158 - Beard; Richard L. ;   et al. | 2013-12-19 |
Aryl Urea Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20130331570 - Beard; Richard L. ;   et al. | 2013-12-12 |
1-aryl -1-hydroxy -2,3-diamino-propyl Amin Es, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20130310383 - Leblond; Bertrand ;   et al. | 2013-11-21 |
1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,580,817 - Beard , et al. November 12, 2 | 2013-11-12 |
1,2-bis-sulfonamide derivatives as chemokine receptor modulators Grant 8,580,779 - Yuan , et al. November 12, 2 | 2013-11-12 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions App 20130296394 - Dibas; Mohammed I. ;   et al. | 2013-11-07 |
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists Grant 8,575,207 - Gil , et al. November 5, 2 | 2013-11-05 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure App 20130289088 - Dibas; Mohammed I. ;   et al. | 2013-10-31 |
S1P3 receptor inhibitors for treating pain Grant 8,563,594 - Donello , et al. October 22, 2 | 2013-10-22 |
(2-ureidoacetamido)alkyl Derivatives As Formyl Peptide Receptor 2 Modulators App 20130274230 - Beard; Richard L. ;   et al. | 2013-10-17 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20130252984 - YUAN; Haiqing ;   et al. | 2013-09-26 |
Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators Grant 8,541,577 - Beard , et al. September 24, 2 | 2013-09-24 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20130237552 - YUAN; HAIQING ;   et al. | 2013-09-12 |
Benzofuran-2-sulfonamides Pyridine Derivatives As Chemokine Receptor Modulators App 20130231339 - YUAN; HAIQING ;   et al. | 2013-09-05 |
Benzofuran-2-sulfonamides Derivatives As Chemokine Receptor Modulators App 20130231338 - YUAN; HAIQING ;   et al. | 2013-09-05 |
Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators Grant 8,524,745 - Yuan , et al. September 3, 2 | 2013-09-03 |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity Grant 8,524,917 - Beard , et al. September 3, 2 | 2013-09-03 |
Phosphorous derivatives as chemokine receptor modulators Grant 8,518,913 - Yuan , et al. August 27, 2 | 2013-08-27 |
Imidazolidine-2,4-dione Derivatives As N-formyl Peptide Receptor 2 Modulators App 20130217720 - Beard; Richard L. ;   et al. | 2013-08-22 |
Method Of Reducing The Severity Of Inflammatory Dermatological Conditions App 20130217694 - Gil; Daniel W. ;   et al. | 2013-08-22 |
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity Grant 8,513,288 - Leblond , et al. August 20, 2 | 2013-08-20 |
Alpha-2 Adrenergic Agonist Having Long Duration Of Intraocular Pressure-lowering Effect App 20130210876 - DONELLO; JOHN E. ;   et al. | 2013-08-15 |
Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity Grant 8,507,560 - Beard , et al. August 13, 2 | 2013-08-13 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20130203809 - Dibas; Mohammed I. ;   et al. | 2013-08-08 |
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-aminopropionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20130202653 - Leblond; Bertrand ;   et al. | 2013-08-08 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure Grant 8,501,796 - Dibas , et al. August 6, 2 | 2013-08-06 |
Brimonidine For Treating Visual Disorders Mediated By Central Visual Projections From The Eye App 20130197002 - Staubli; Ursula ;   et al. | 2013-08-01 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20130190338 - YUAN; HAIQING ;   et al. | 2013-07-25 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions Grant 8,492,422 - Dibas , et al. July 23, 2 | 2013-07-23 |
2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,492,556 - Beard , et al. July 23, 2 | 2013-07-23 |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol Grant 8,492,557 - Chow , et al. July 23, 2 | 2013-07-23 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20130165460 - YUAN; Haiqing ;   et al. | 2013-06-27 |
Benzisothiazol-3(1h)-one-5-sulfonyl Derivatives As Chemokine Receptor Modulators App 20130150413 - Yuan; Haiqing ;   et al. | 2013-06-13 |
Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists Grant 8,455,548 - Luhrs , et al. June 4, 2 | 2013-06-04 |
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists App 20130137725 - Luhrs; Lauren M.B. ;   et al. | 2013-05-30 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Retinal Neuroprotection App 20130137724 - Dibas; Mohammed I. ;   et al. | 2013-05-30 |
Sulfur derivatives as chemokine receptor modulators Grant 8,450,367 - Yuan , et al. May 28, 2 | 2013-05-28 |
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases App 20130131133 - Dibas; Mohammed I. ;   et al. | 2013-05-23 |
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions App 20130123303 - Dibas; Mohammed I. ;   et al. | 2013-05-16 |
Aryl Urea Derivatives As N-formyl Peptide Receptors Like-1 (fprl-1) Receptor Modulators App 20130123496 - Beard; Richard L. ;   et al. | 2013-05-16 |
2,5-dioxoimidazolidin-1-yl-3-phenylurea Derivatives As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20130123215 - Beard; Richard L. ;   et al. | 2013-05-16 |
Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators Grant 8,440,684 - Beard , et al. May 14, 2 | 2013-05-14 |
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20130109866 - Beard; Richard L. ;   et al. | 2013-05-02 |
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds Grant 8,431,702 - Sinha , et al. April 30, 2 | 2013-04-30 |
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity Grant 8,431,599 - Leblond , et al. April 30, 2 | 2013-04-30 |
Topical Dermal Brimonidine Compositions App 20130102612 - Gil; Daniel W. ;   et al. | 2013-04-25 |
Compositions and methods for treating seizure disorders Grant 8,404,721 - Donello , et al. March 26, 2 | 2013-03-26 |
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Retinal Diseases App 20130046003 - Dibas; Mohammed I. ;   et al. | 2013-02-21 |
Compositiions For Treating Cognitive Disorders App 20130040938 - Stabuli; Ursula V. ;   et al. | 2013-02-14 |
Aromatic Bycyclic Derivatives As Cxcr4 Receptor Modulators App 20130035347 - Vuligonda; Vidyasagar ;   et al. | 2013-02-07 |
Alpha-2 Adrenergic Modulators For Treating Visual Disorders Mediated By Central Visual Projections From The Eye App 20130023573 - Staubli; Ursula V. ;   et al. | 2013-01-24 |
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Skin Diseases App 20130023572 - Dibas; Mohammed I. ;   et al. | 2013-01-24 |
Polycyclic Pyrrolidine-2,5-dione Derivatives As -formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20130018067 - Beard; Richard L. ;   et al. | 2013-01-17 |
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20130005717 - Leblond; Bertrand ;   et al. | 2013-01-03 |
D-serine For The Treatment Of Visual System Disorders App 20120329873 - Li; YONG-XIN ;   et al. | 2012-12-27 |
Targeted Delivery of Retinoid Compounds to the Sebaceous Glands App 20120328670 - Donello; John E. ;   et al. | 2012-12-27 |
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS App 20120309782 - Sinha; Santosh C. ;   et al. | 2012-12-06 |
Methods of Preventing and Reducing the Severity of Stress-Associated Conditions App 20120302574 - Gil; Daniel W. ;   et al. | 2012-11-29 |
Compositions And Methods For Treating Seizure Disorders App 20120295936 - Donello; John E. ;   et al. | 2012-11-22 |
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds Grant 8,309,729 - Sinha , et al. November 13, 2 | 2012-11-13 |
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity Grant 8,288,556 - Leblond , et al. October 16, 2 | 2012-10-16 |
Dihydronaphthalene And Naphthalene Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators App 20120238628 - Vuligonda; Vidyasagar ;   et al. | 2012-09-20 |
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl Amines, 3-benzyl-3-hyrdroxy-2-amino-propionic Acid Amides And Related Compounds App 20120225881 - Leblond; Bertrand ;   et al. | 2012-09-06 |
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS App 20120214838 - Sinha; Santosh C. ;   et al. | 2012-08-23 |
Methods For Treating Diseases Of The Retina App 20120214842 - Donello; John E. ;   et al. | 2012-08-23 |
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde10a) App 20120214837 - Leblond; Bertrand ;   et al. | 2012-08-23 |
Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators App 20120208842 - Beard; Richard L. ;   et al. | 2012-08-16 |
Alpha Adrenergic Receptor Modulators App 20120208821 - Chow; Ken ;   et al. | 2012-08-16 |
Compositions and methods for treating seizure disorders Grant 8,242,141 - Donello , et al. August 14, 2 | 2012-08-14 |
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same App 20120196911 - Heidelbaugh; Todd M. ;   et al. | 2012-08-02 |
Methods Of Treating Motor Disorders With Alpha-2b Andrenergic Receptor Agonists App 20120190719 - Gil; Daniel W. ;   et al. | 2012-07-26 |
Methods for Treating Cognitive Disorders App 20120190712 - Donello; John E. ;   et al. | 2012-07-26 |
Compositions and methods for treating spasticity Grant 8,217,059 - Gil , et al. July 10, 2 | 2012-07-10 |
Methods for treating anxiety Grant 8,211,917 - Donello , et al. July 3, 2 | 2012-07-03 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20120165380 - Gil; Daniel W. ;   et al. | 2012-06-28 |
Compounds Having Analgesic And/or Immunostimulant Activity App 20120157497 - Leblond; Bertrand ;   et al. | 2012-06-21 |
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators App 20120157444 - Yuan; Haiqing ;   et al. | 2012-06-21 |
Sulfur Derivatives As Chemokine Receptor Modulators App 20120157487 - Yuan; Haiqing ;   et al. | 2012-06-21 |
Phosphorous Derivatives As Chemokine Receptor Modulators App 20120157413 - Yuan; Haiqing ;   et al. | 2012-06-21 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases App 20120149746 - Dibas; Mohammed I. ;   et al. | 2012-06-14 |
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol App 20120149747 - Dibas; Mohammad I. ;   et al. | 2012-06-14 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure App 20120142746 - Dibas; Mohammed I. ;   et al. | 2012-06-07 |
Pharmaceutical Compositions Comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea Derivatives Having Formyl Peptide Receptor Like-1 (fprl-1) Agonist Or Antagonist Activity App 20120142726 - Beard; Richard L. ;   et al. | 2012-06-07 |
Bicyclic compounds having activity at the CXCR4 receptor Grant 8,193,203 - Beard , et al. June 5, 2 | 2012-06-05 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions App 20120136036 - Dibas; Mohammed I. ;   et al. | 2012-05-31 |
Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists App 20120136041 - Rodrigues; Gerard A. ;   et al. | 2012-05-31 |
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds Grant 8,188,279 - Sinha , et al. May 29, 2 | 2012-05-29 |
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol App 20120122945 - Chow; Ken ;   et al. | 2012-05-17 |
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha.sub.2 adrenergic agonists and methods for using the same Grant 8,178,571 - Heidelbaugh , et al. May 15, 2 | 2012-05-15 |
Methods for treating cognitive disorders Grant 8,173,683 - Donello , et al. May 8, 2 | 2012-05-08 |
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity Grant 8,168,631 - Leblond , et al. May 1, 2 | 2012-05-01 |
Compounds having analgesic and/or immunostimulant activity Grant 8,153,666 - Leblond , et al. April 10, 2 | 2012-04-10 |
Treating pain using selective antagonists of persistent sodium current Grant 8,153,645 - Ehring , et al. April 10, 2 | 2012-04-10 |
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain App 20120083508 - Gil; Daniel W. ;   et al. | 2012-04-05 |
Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity Grant 8,143,291 - Beard , et al. March 27, 2 | 2012-03-27 |
S1P3 Receptor Inhibitors for Treating Conditions of the Eye App 20120071448 - Donello; John E. ;   et al. | 2012-03-22 |
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists App 20120041031 - Gil; Daniel W. ;   et al. | 2012-02-16 |
Methods Of Treating Alpha Adrenergic Mediated Conditions App 20120035235 - Fang; Wenkui K. ;   et al. | 2012-02-09 |
Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist Grant 8,097,644 - Beard , et al. January 17, 2 | 2012-01-17 |
Compositions and Methods for the Treatment of Ophthalmic Disease App 20120003275 - Rodrigues; Gerard A. ;   et al. | 2012-01-05 |
Derivatives Of Cycloalkyl- And Cycloalkenyl-1,2-dicarboxylic Acid Compounds Having Formyl Peptide Receptor Like-1 (fprl-1) Agonist Or Antagonist Activity App 20110319454 - Beard; Richard L. ;   et al. | 2011-12-29 |
Methods of treating alpha adrenergic mediated conditions Grant 8,071,636 - Fang , et al. December 6, 2 | 2011-12-06 |
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20110288094 - Leblond; Bertrand ;   et al. | 2011-11-24 |
Indole Compounds Bearing Aryl Or Heteroaryl Groups Having Sphingosine-1-phosphate (s1p) Receptor Biological Activity App 20110275677 - Beard; Richard L. ;   et al. | 2011-11-10 |
Method Of Treating Sensorimotor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione App 20110269805 - Gil; Daniel W. ;   et al. | 2011-11-03 |
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS App 20110237797 - Sinha; Santosh C. ;   et al. | 2011-09-29 |
Nonsedating .alpha.-2 agonists Grant 8,022,226 - Chow , et al. September 20, 2 | 2011-09-20 |
3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity Grant 8,013,000 - Leblond , et al. September 6, 2 | 2011-09-06 |
Compositions And Methods For Treating Spasticity App 20110212995 - Gil; Daniel W. ;   et al. | 2011-09-01 |
Alpha-2 Adrenergic Agonist Having Long Duration Ofintraocular Pressure-lowering Effect App 20110178145 - Donello; John E. ;   et al. | 2011-07-21 |
Treatment Of Inflammatory Bowel Disease App 20110172435 - Donde; Yariv ;   et al. | 2011-07-14 |
Methods of preventing and reducing the severity of stress-associated conditions Grant 7,977,335 - Gil , et al. July 12, 2 | 2011-07-12 |
Method Of Treating Motor Disorders With Alpha-2b Adrenergic Receptor Agonists App 20110160265 - Luhrs; Lauren M.B. ;   et al. | 2011-06-30 |
Compositions and methods for the treatment of ophthalmic disease Grant 7,964,191 - Rodrigues , et al. June 21, 2 | 2011-06-21 |
Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity App 20110105567 - Beard; Richard L. ;   et al. | 2011-05-05 |
Compositions And Methods For Treating Disorders Of Gastrointestinal Motility App 20110065748 - Donello; John E. | 2011-03-17 |
Compositions And Methods For Treating Seizure Disorders App 20110065747 - Donello; John E. ;   et al. | 2011-03-17 |
Therapeutic Quinoline And Naphthalene Derivatives App 20110046177 - Beard; Richard L. ;   et al. | 2011-02-24 |
Ccr2 Inhibitors For Treating Conditions Of The Eye App 20110038871 - Viswanth; Veena ;   et al. | 2011-02-17 |
Isothiozoles For Treating Conditions Of The Eye App 20110039900 - Viswanath; Veena ;   et al. | 2011-02-17 |
Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity Grant 7,888,336 - Beard , et al. February 15, 2 | 2011-02-15 |
Nonsedating Alpha-2 Agonists App 20110034525 - Chow; Ken ;   et al. | 2011-02-10 |
Methods and compositions for the treatment of pain and other neurological conditions Grant 7,884,115 - Donello , et al. February 8, 2 | 2011-02-08 |
Compositions For Treating Cognitive Disorders App 20110015179 - Staubli; Ursula V. ;   et al. | 2011-01-20 |
S1p3 Receptor Inhibitors For Treating Inflammation App 20110009453 - Donello; John E. ;   et al. | 2011-01-13 |
Treatment of inflammatory bowel disease Grant 7,855,226 - Donde , et al. December 21, 2 | 2010-12-21 |
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same App 20100298395 - Heidelbaugh; Todd M. ;   et al. | 2010-11-25 |
4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists Grant 7,838,545 - Heidelbaugh , et al. November 23, 2 | 2010-11-23 |
S1p3 Receptor Inhibitors For Treating Pain App 20100249069 - Donello; John E. ;   et al. | 2010-09-30 |
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists App 20100240699 - Luhrs; Lauren M.B. ;   et al. | 2010-09-23 |
Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity App 20100240614 - Beard; Richard L. ;   et al. | 2010-09-23 |
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same Grant 7,795,292 - Heidelbaugh , et al. September 14, 2 | 2010-09-14 |
Method Of Treating Motor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione App 20100216857 - Luhrs; Lauren M.B. ;   et al. | 2010-08-26 |
Methods For Treating Anxiety App 20100197730 - Donello; John E. ;   et al. | 2010-08-05 |
Treating pain using selective antagonists of persistent sodium current Grant 7,767,718 - Ehring , et al. August 3, 2 | 2010-08-03 |
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20100190792 - Donello; John E. ;   et al. | 2010-07-29 |
Treating pain using selective antagonists of persistent sodium current Grant 7,763,651 - Ehring , et al. July 27, 2 | 2010-07-27 |
Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists App 20100183696 - Rodrigues; Gerard A. ;   et al. | 2010-07-22 |
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity Grant 7,737,173 - Beard , et al. June 15, 2 | 2010-06-15 |
Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity Grant 7,728,014 - Beard , et al. June 1, 2 | 2010-06-01 |
Methods For Treating Cognitive Disorders Using 1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds App 20100105687 - Donello; John E. ;   et al. | 2010-04-29 |
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20100093793 - Donello; John E. ;   et al. | 2010-04-15 |
Substituted 3-amino-1-oxo Or Thioxo-1,2,5,6,7,8-hexahydro-2,7-naphthyridine-4-carbonitriles Are Selective Alpha 2b Antagonists App 20100076194 - CAPPIELLO; John R. ;   et al. | 2010-03-25 |
4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists Grant 7,683,089 - Heidelbaugh , et al. March 23, 2 | 2010-03-23 |
Methods For Treating Cognitive Disorders App 20100048642 - Donello; John E. ;   et al. | 2010-02-25 |
Alpha-2 Receptor Pan Agonist And Anticonvulsant Compositions For Treating Chronic Pain App 20100029618 - Gil; Daniel W. ;   et al. | 2010-02-04 |
Methods for detecting receptor modulator activity Grant 7,655,396 - Kedzie , et al. February 2, 2 | 2010-02-02 |
Alpha-2b Adrenergic Receptor Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain App 20100016355 - Gil; Daniel W. ;   et al. | 2010-01-21 |
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS App 20100009985 - SINHA; Santosh C. ;   et al. | 2010-01-14 |
Compounds Having Analgesic And/or Immunostimulant Activity App 20090318499 - Leblond; Bertrand ;   et al. | 2009-12-24 |
Bicyclic Compounds Having Activity At The Cxcr4 Receptor App 20090312305 - Beard; Richard L. ;   et al. | 2009-12-17 |
THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS App 20090281322 - Sinha; Santosh C. ;   et al. | 2009-11-12 |
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic Activity App 20090281085 - Leblond; Bertrand ;   et al. | 2009-11-12 |
4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-- 2-thione as specific alpha.sub.2b agonist and methods of using the same Grant 7,569,584 - Heidelbaugh , et al. August 4, 2 | 2009-08-04 |
4-(condensed Cyclicmethyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists App 20090176828 - Heidelbaugh; Todd M. ;   et al. | 2009-07-09 |
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds App 20090088433 - Leblond; Bertrand ;   et al. | 2009-04-02 |
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity App 20090036436 - Leblond; Bertrand ;   et al. | 2009-02-05 |
3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity App 20080312236 - Leblond; Bertrand ;   et al. | 2008-12-18 |
4-(heteroaryl-methyl And Substituted Heteroaryl-methyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists App 20080221152 - Heidelbaugh; Todd M. ;   et al. | 2008-09-11 |
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions App 20080207628 - Gil; Daniel W. ;   et al. | 2008-08-28 |
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions App 20080207627 - Gil; Daniel W. ;   et al. | 2008-08-28 |
Nonsedating Alpha-2 Agonists App 20080176918 - Chow; Ken ;   et al. | 2008-07-24 |
6-substituted Indole-3-carboxylic Acid Amide Compounds Having Sphingosine-1-phosphate (s1p) Receptor Antagonist Biological Activity App 20080171772 - Beard; Richard L. ;   et al. | 2008-07-17 |
4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists Grant 7,399,868 - Heidelbaugh , et al. July 15, 2 | 2008-07-15 |
4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as .alpha..sub.2 adrenergic agonists Grant 7,396,849 - Heidelbaugh , et al. July 8, 2 | 2008-07-08 |
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain App 20080153874 - Gil; Daniel W. ;   et al. | 2008-06-26 |
Alpha-2 Receptor Pan Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain App 20080153808 - Gil; Daniel W. ;   et al. | 2008-06-26 |
Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists App 20080132543 - Im; Wha Bin ;   et al. | 2008-06-05 |
Compositions Comprising Nb-Dnj, Ne-Dnj Or D-Glucaro-Delta-Lactam And Their Uses For The Treatment Of Pain And Other Neurological Condittions App 20080085920 - Donello; John E. ;   et al. | 2008-04-10 |
4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-- 2-thione As Specific Alpha2b Agonist And Methods Of Using The Same App 20080070945 - Heidelbaugh; Todd M. ;   et al. | 2008-03-20 |
Methods and compositions for alleviating pain Grant 7,345,065 - Gil , et al. March 18, 2 | 2008-03-18 |
Heteroaromatic Compounds Having Sphingosine-1-phosphate (s1p) Receptor Agonist Biological Activity App 20080064872 - Beard; Richard L. ;   et al. | 2008-03-13 |
Nonsedating .alpha.-2 agonists Grant 7,312,238 - Chow , et al. December 25, 2 | 2007-12-25 |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds Grant 7,276,522 - Heidelbaugh , et al. October 2, 2 | 2007-10-02 |
Nonsedating .alpha.-2 agonists Grant 7,141,597 - Chow , et al. November 28, 2 | 2006-11-28 |
Treating pain using selective antagonists of persistent sodium current Grant 7,125,908 - Ehring , et al. October 24, 2 | 2006-10-24 |
Method for treating ocular pain Grant 6,294,553 - Gil , et al. September 25, 2 | 2001-09-25 |